Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Free Cash Flow Generation Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Free Cash Flow Generation Index of -1.24x as of December 2024. Free cash flow of CN¥-58.25 Million represents -1% of operating cash flow (CN¥47.07 Million). Explore Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Suzhou Fushilai Pharmaceutical Co. Ltd..
Annual Free Cash Flow Generation for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for Suzhou Fushilai Pharmaceutical Co. Ltd.. Check 301258 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.24x | CN¥-58.25 Million | CN¥47.07 Million | CN¥105.31 Million | ▼ -320.7% |
| 2023 | 0.56x | CN¥53.15 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -16.1% |
| 2022 | 0.67x | CN¥101.08 Million | CN¥151.19 Million | CN¥50.11 Million | ▲ +12.2% |
| 2021 | 0.60x | CN¥118.98 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -1.7% |
| 2020 | 0.61x | CN¥101.16 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +14.6% |
| 2019 | 0.53x | CN¥79.62 Million | CN¥150.55 Million | CN¥70.93 Million | — |